Joel David Mayersohn
Known title: DirectorCIK: 0001588395
Associated companies
Transaction History
| CTOR | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 | View on chart |
| CTOR | ▼ Sell | Other | 21,228 | $0 | 7/28/2025 | View on chart |
| CTOR | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 | View on chart |
| CTOR | ▼ Sell | Other | 21,228 | $0 | 7/28/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTOR to Join October 2026 Investor Conferences
Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.
CTOR to Join October 2026 Investor Conferences. Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.